To the full analysis
Sinoma Science & Technology stock: growth
002080.SZSinoma Science & Technology reported $4.52B in revenue for fiscal 2025, up 25.5% on the prior year, up 9.8% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
22.4%
per year from 2006 to 2025, per share 14.7%
Earnings (Annual rate)
20%
per year from 2006 to 2025, per share 12.3%
Free cash flow (Annual rate)
no data
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 9.8% | 12.6% | 22.4% |
| Revenue per share | 9.8% | 10.5% | 14.7% |
| Earnings | −2.3% | 11.2% | 20.0% |
| Earnings per share | −2.4% | 9.1% | 12.3% |
| Free cash flow | 26.9% | 16.5% | no data |
| Free cash flow per share | 26.9% | 14.4% | no data |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $97.45M | $8.57M | −$16.61M |
| 2007 | $133M | $11.26M | −$28.35M |
| 2008 | $161.5M | $14.11M | −$35.03M |
| 2009 | $241.87M | $16.25M | −$26.88M |
| 2010 | $385.93M | $26.54M | −$32.55M |
| 2011 | $379.63M | $18.22M | −$36.92M |
| 2012 | $425.06M | $18.64M | −$34.1M |
| 2013 | $516.34M | $16.19M | −$33.03M |
| 2014 | $663.51M | $22.82M | $2.41M |
| 2015 | $1.38B | $94.53M | $59.79M |
| 2016 | $1.3B | $60.2M | −$33.41M |
| 2017 | $1.54B | $115.07M | −$116.72M |
| 2018 | $1.71B | $139.43M | −$22.07M |
| 2019 | $2.04B | $206.95M | $118.9M |
| 2020 | $2.83B | $305.86M | $84.04M |
| 2021 | $3.04B | $505.89M | $280.22M |
| 2022 | $3.87B | $536.04M | −$244.76M |
| 2023 | $3.88B | $333.42M | −$441.35M |
| 2024 | $3.6B | $133.75M | −$144.22M |
| 2025 | $4.52B | $272.6M | $276.5M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = CN¥6.6683)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 9 Oct 2026)
- Valuation signal Overvalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.